Literature DB >> 23078103

Complement C3 is a substrate for activated factor XIII that is cross-linked to fibrin during clot formation.

Victoria R Richardson, Verena Schroeder, Peter J Grant, Kristina F Standeven, Angela M Carter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23078103     DOI： 10.1111/bjh.12096

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  5 in total

Review 1.  Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk.

Authors:  Katherine Kearney; Darren Tomlinson; Kerrie Smith; Ramzi Ajjan
Journal:  Cardiovasc Diabetol       Date:  2017-03-09       Impact factor: 9.951

Review 2.  Fibrinogen and Antifibrinolytic Proteins: Interactions and Future Therapeutics.

Authors:  Nikoletta Pechlivani; Katherine J Kearney; Ramzi A Ajjan
Journal:  Int J Mol Sci       Date:  2021-11-21       Impact factor: 5.923

3.  Exploring the function of factor XIII free B subunit: Interactions with complement factors and a novel approach to identify potential binding partners.

Authors:  Bojun Li; Clément Bechtler; Lorenz Jenny; Daniel Ricklin; Verena Schroeder
Journal:  Res Pract Thromb Haemost       Date:  2022-07-21

4.  Alternative Complement Pathway Activation Provokes a Hypercoagulable State with Diminished Fibrinolysis.

Authors:  Jason M Samuels; Julia R Coleman; Ernest E Moore; Matt Bartley; Navin Vigneshwar; Mitchell Cohen; Christopher C Silliman; Angela Sauaia; Anirban Banerjee
Journal:  Shock       Date:  2020-05       Impact factor: 3.533

Review 5.  Inhibition of Fibrinolysis by Coagulation Factor XIII.

Authors:  Dingeman C Rijken; Shirley Uitte de Willige
Journal:  Biomed Res Int       Date:  2017-07-06       Impact factor: 3.411
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.